CHOLESTYRAMINE LIGHT Drug Patent Profile
✉ Email this page to a colleague
When do Cholestyramine Light patents expire, and when can generic versions of Cholestyramine Light launch?
Cholestyramine Light is a drug marketed by Alkem Labs Ltd, Epic Pharma Llc, Par Pharm, Tagi, Teva, Teva Pharms, and Zydus Pharms. and is included in seven NDAs.
The generic ingredient in CHOLESTYRAMINE LIGHT is cholestyramine. There are eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cholestyramine Light
A generic version of CHOLESTYRAMINE LIGHT was approved as cholestyramine by EPIC PHARMA LLC on August 15th, 1996.
Summary for CHOLESTYRAMINE LIGHT
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 7 |
| Finished Product Suppliers / Packagers: | 10 |
| Clinical Trials: | 37 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CHOLESTYRAMINE LIGHT at DailyMed |
Recent Clinical Trials for CHOLESTYRAMINE LIGHT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Eli Lilly and Company | Phase 1 |
| Loxo Oncology, Inc. | Phase 1 |
| Ain Shams University | Phase 4 |
Pharmacology for CHOLESTYRAMINE LIGHT
| Drug Class | Bile Acid Sequestrant |
| Mechanism of Action | Bile-acid Binding Activity |
US Patents and Regulatory Information for CHOLESTYRAMINE LIGHT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alkem Labs Ltd | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 211799-001 | Oct 19, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Tagi | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 209599-001 | Nov 12, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Epic Pharma Llc | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 074558-002 | Aug 15, 1996 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Teva Pharms | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 074555-002 | Sep 30, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Tagi | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 209599-002 | Nov 12, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Alkem Labs Ltd | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 211799-002 | Oct 19, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
